Comparison Of Latanoprost 0.005% And Travoprost 0.004% In Patients With Primary Open Angle Glaucoma And Ocular Hypertension
DOI:
https://doi.org/10.59928/ebnz4077Keywords:
primary open-angle glaucoma, latanoprost, travoprost, intraocular pressureAbstract
This study compares the hypotensive effect of latanoprost 0.005% and travoprost 0.004% solutions in primary open-angle glaucoma or ocular hypertensive patients. In this prospective, multicenter clinical trial, 100 patients received either latanoprost once daily in the evening (n = 50), or travoprost once daily in the evening (n = 50). Efficacy was compared across treat ment groups over 6 months. Mean intraocular pressure at the first visit in the latanoprost 0.005% group was 26.2 mmHg (SD ± 1.9 mmHg), and 17.5 mmHg (SD ± 1.2 mmHg) at the fifth visit (after 6 months). In the travoprost group, the mean intraocular pressure in the first visit was 26.3 mmHg (SD ± 1.9 mmHg), and 18.4 mmHg (SD ± 1.5 mmHg) in the fifth visit. In both groups, there was a statistically significant differ ence in intraocular pressure between the first and firth visits, for both eyes. Both latanoprost and travoprost showed similar hypotensive effect with the first one being slightly more potent in reducing the IOP.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 The Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License.